Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Aitor Uribarri and Pablo Catalá.
Aitor Uribarri
Connection Strength
0.582
Pablo Catalá
  1. Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19. Cardiol J. 2021; 28(3):360-368.
    View in: PubMed
    Score: 0.235
  2. Atrial fibrillation in patients with SARS-CoV-2 infection. Med Clin (Engl Ed). 2021 Jul 23; 157(2):58-63.
    View in: PubMed
    Score: 0.060
  3. Exercise Ventilatory Inefficiency in Post-COVID-19 Syndrome: Insights from a Prospective Evaluation. J Clin Med. 2021 Jun 11; 10(12).
    View in: PubMed
    Score: 0.059
  4. Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis. Med Clin (Barc). 2021 May 06.
    View in: PubMed
    Score: 0.059
  5. Atrial fibrillation in patients with SARS-CoV-2 infection. Med Clin (Barc). 2021 07 23; 157(2):58-63.
    View in: PubMed
    Score: 0.058
  6. The presence of heart disease worsens prognosis in patients with COVID-19. Rev Esp Cardiol (Engl Ed). 2020 09; 73(9):773-775.
    View in: PubMed
    Score: 0.055
  7. [The presence of heart disease worsens prognosis in patients with COVID-19]. Rev Esp Cardiol. 2020 Sep; 73(9):773-775.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.